Angiotensin I recovery from plasma incubated with organic reagents.
(1) In order to explore the possible mechanism that organic reagents used in the incubation step of the plasma renin activity (PRA) analysis act as a angiotensinase inhibitors we did angiotensin I (AI) recovery studies from plasma with such reagents. The organic acids and their mean difference in percent recovery of AI as compared to that for hydrochloric acid (HCI) are respectively as follows for one and a three hour incubation time: maleic (0.7%, 4.5%); and potassium hydrogen phthalate (KHphthalate) (7.2%, 9.6%). The tris(hydroxymethyl)aminomethane (Tris) organic acid salts and their mean difference in percent recovery of AI as compared to that for Tris-HCl are as follows for a one hour incubation: Tris-acetylsalicylate (3.6%), Tris-phenoxyacetate (3.6%), Tris-benzoate (2.6%), and Tris-salicylate (4.9%). (2) Of the reagents studied KHphthalate after a three hour incubation produced a statistically significant difference from the HCl reagent. The recovery data for all the organic reagents suggested that the primary mechanism of action was not that of an angiotensinase inhibitory one.
D000803:Angiotensin I / Q000097:blood*; D000809:Angiotensins / Q000097:blood*; D001241:Aspirin; D001565:Benzoates; D002021:Buffers; D006801:Humans; D006851:Hydrochloric Acid; D008298:Maleates; D010642:Phenoxyacetates; D010795:Phthalic Acids; D011480:Protease Inhibitors; D012459:Salicylates; D014325:Tromethamine
D000809:Angiotensins; D001565:Benzoates; D002021:Buffers; D008298:Maleates; D010642:Phenoxyacetates; D010795:Phthalic Acids; D011480:Protease Inhibitors; D012459:Salicylates; D014325:Tromethamine; C032279:phthalic acid; D000803:Angiotensin I; C030272:maleic acid; D006851:Hydrochloric Acid; D001241:Aspirin